Q2Earth’s Bioscience Subsidiary, QSAM Therapeutics, Signs License for Promising Drug to Treat Bone Cancer Read more
Pneumagen Ltd Announces Positive Anti-Viral Activity for Novel Glycan Approach in Preventing Coronavirus (COVID-19) Infections Read more
Sutro Biopharma Announces Encouraging Interim Phase 1 Clinical Data For Stro-002 Antibody-Drug Conjugate In Ovarian Cancer Read more
Takeda gets FDA breakthrough therapy status for mobocertinib to treat certain type of lung cancer Read more
Merck and ISB Collaborate to Define Molecular Mechanisms of SARS-CoV-2 Infection and Identify Potential Prognostic Biomarkers Read more